Bronchitis

Community-acquired pneumonia is a lower respiratory tract infection acquired outside the hospital that is diagnosed by a compatible clinical syndrome plus a new infiltrate on chest imaging, risk-stratified with CURB-65 or the Pneumonia Severity Index to guide site of care, and treated with empiric antibiotics chosen by site of care and comorbidity, escalating to cover MRSA or Pseudomonas aeruginosa when risk factors are present.

Influenza is an acute orthomyxoviral respiratory illness with abrupt fever, myalgia, and cough, driven by an H and N surface glycoprotein antigenicity that drifts yearly (seasonal epidemics) and occasionally shifts (pandemics). Diagnosis is clinical or confirmed by nucleic acid amplification testing, and neuraminidase-inhibitor or endonuclease-inhibitor antiviral therapy started within 48 hours of onset shortens illness and reduces complications in high-risk patients.

Whooping cough is a highly infectious bronchitis caused by the gram-negative coccobacillus Bordetella pertussis, marked by catarrhal, paroxysmal, and convalescent stages with lymphocytosis; diagnosis is clinical, confirmed by nasopharyngeal PCR, and treated with azithromycin plus prophylaxis of close contacts.

Asthma is a chronic inflammatory airway disorder causing episodic, reversible airflow obstruction confirmed by spirometry or bronchial challenge testing. Management is a stepwise ladder led by inhaled glucocorticoids plus as-needed SABA or ICS-formoterol, escalating to biologics for severe type 2-high disease, with an oral glucocorticoid burst and frequent SABA for exacerbations.

Chronic obstructive pulmonary disease is a persistent, usually progressive airflow obstruction driven mainly by cigarette smoke, confirmed by a postbronchodilator FEV1/forced vital capacity (FVC) ratio below 0.70 and staged by GOLD spirometric grade plus symptom/exacerbation group. Maintenance management is a stepwise ladder of smoking cessation, long-acting bronchodilators, add-on inhaled glucocorticoid, roflumilast, or azithromycin for frequent exacerbators, long-term oxygen for resting hypoxemia, and vaccination, with acute exacerbations managed as a separate protocol.

Acute rhinosinusitis is inflammation of the nasal cavity and paranasal sinuses lasting up to 4 weeks, presenting with purulent nasal discharge plus nasal obstruction or facial pain/pressure/fullness. Most cases are viral and treated with acetaminophen/ibuprofen plus nasal saline irrigation alone; a minority are bacterial, identified by persistence beyond 10 days, a biphasic worsening course, or severe onset, and treated with amoxicillin-clavulanate 875/125 mg PO every 12 hours for 5 to 7 days.

GERD is retrograde reflux of gastric contents into the esophagus causing heartburn and regurgitation, diagnosed clinically and confirmed by response to an empiric PPI trial, with endoscopy reserved for alarm features or refractory symptoms. Management proceeds from lifestyle measures through an 8-week once-daily PPI trial, dose escalation or agent switch for partial response, and fundoplication for medication-refractory or regurgitation-predominant disease.

Pulmonary embolism is thrombus, usually from a lower-extremity deep vein thrombosis, obstructing the pulmonary arterial circulation and causing V/Q mismatch, right ventricular strain, and hypoxemia. Diagnosis follows Wells criteria (with PERC in low-risk patients) to sequence D-dimer, CT pulmonary angiography, and V/Q scanning, and management is risk-stratified anticoagulation escalating to thrombolysis or embolectomy for hemodynamic instability.